Literature DB >> 6651865

Iron mobilization from cultured hepatocytes: effect of desferrioxamine B.

J N Octave, Y J Schneider, R R Crichton, A Trouet.   

Abstract

When cultured rat hepatocytes prelabelled for different times at 37 degrees with 59Fe are reincubated for 1 hr in a fresh medium, radiolabelled iron is released in the washout medium as a function of the prelabelling time, and behaves like low molecular weight material on isokinetic centrifugation in sucrose gradients. When apotransferrin or desferrioxamine B are present in the reincubation medium, the kinetics of iron release are similar but the absolute amounts of radiolabelled iron found in the culture medium are much greater. In the presence of apotransferrin, most of the 59Fe released from the cells distributes as transferrin whereas with desferrioxamine B, almost all the 59Fe is extracted by benzyl alcohol indicating its chelation by the drug. Cell fractionation data indicate that iron accumulated by hepatocytes is rapidly incorporated into cytosol ferritin, and this seems to be a preferred source of iron for the chelator.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6651865     DOI: 10.1016/0006-2952(83)90370-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  Effect of ATP depletion and temperature on the transferrin-mediated uptake and release of iron by BeWo choriocarcinoma cells.

Authors:  A van der Ende; A du Maine; A L Schwartz; G J Strous
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

2.  Chelation of transferrin iron by desferrioxamine in K562 cells. The partition of iron between ferrioxamine and ferritin.

Authors:  S Roberts; A Bomford
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

3.  Phylogenetic analyses uncover a novel clade of transferrin in nonmammalian vertebrates.

Authors:  Hirzahida Mohd-Padil; Adura Mohd-Adnan; Toni Gabaldón
Journal:  Mol Biol Evol       Date:  2012-12-19       Impact factor: 16.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.